Category: Finance
-
Network to Promote Real-World Dementia Trials
University and senior care center researchers are building a nationwide network to collect real-world evidence on caring for people with dementia.
-
Gene-Editing Biotech Gains $34M in Early Funds
A two year-old enterprise spun-off from Yale University is developing gene-editing treatments for genetic disorders with synthetic peptides and DNA delivered in nanoscale particles.
-
Sumitomo Dainippon, Biotechs in $3B Acquisition Deal
Japanese pharmaceutical company Sumitomo Dainippon agreed to acquire five biotechnology companies and gain an equity stake in the Roivant Sciences group.
-
Gates Investing in HIV, Tuberculosis Immunotherapies
The Bill and Melinda Gates Foundation is taking an equity stake in a biotechnology company developing immunotherapies from messenger RNA.
-
Infographic – Biotech Index Falls in Summer
It’s time to check in again on the NBI on its ups and downs since the start of 2019, our infographic for this weekend.
-
Math Model to Gauge Heart Attack Risk from Plaques
An academic-industry collaboration is creating a non-invasive technique to detect rupture-prone plaque build-ups in arteries and predict one’s risk of heart attack.
-
Small Biz Grant Funds Pre-Term Gut Microbe Therapy
National Institutes of Health is supporting development of an extended-release probiotic treatment for necrotizing enterocolitis, an intestinal disease affecting premature infants.
-
Carb-X Funds Drug-Resistant Bacterial Vaccine
A company developing vaccines with synthetic biology is receiving a grant for a vaccine to prevent infections from drug-resistant Klebsiella pneumoniae bacteria.
-
Aging Therapy Network Adds $100M to Venture Round
An enterprise supporting a group of companies developing new drugs to address the aging process raised another $100 million in its second venture funding round.
-
Hispanic Neuro Disease Landscape Mapped in New Study
A new project examines brain pathologies leading to development of Alzheimer’s disease in Americans of Hispanic descent, a group largely ignored in neuroscience.